HAVCR2 and laryngotracheoesophageal cleft: TIM-3 (HAVCR2) could be detected in NSCLC, colorectal cancer and HNSC, and served as the predictor to independently predict LC and CRC (Jie et al., 2013; Du et al., 2017; Yu et al., 2017).